SYTO probes: markers of apoptotic cell demise

Donald Wlodkowic1, Joanna Skommer

  • 1University of Glasgow, UK.

Insights

New SYTO probes offer a rapid, high-throughput method for detecting apoptosis, a key type of tumor cell death. These DNA-binding dyes are valuable tools for multiparameter flow cytometry in cancer research.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Cancer Research

Background:

  • Advancing mechanistic studies of tumor cell death requires efficient analytical tools.
  • SYTO probes are emerging as user-friendly markers for caspase-dependent apoptosis.
  • Their spectral properties facilitate multiparameter flow cytometry assay development.

Purpose of the Study:

  • To provide protocols for multiparametric assessment of apoptotic events using SYTO probes.
  • To demonstrate the utility of SYTO probes in conjunction with other cell death markers.

Main Methods:

  • Utilizing green fluorescent SYTO 16 and red fluorescent SYTO 17 dyes with plasma membrane permeability markers.
  • Employing SYTO 16 with tetramethylrhodamine methyl ester (TMRM) to assess mitochondrial membrane potential.
  • Combining SYTO 16 with 7-aminoactinomycin D (7-AAD) as a plasma membrane permeability marker.

Main Results:

  • Established protocols for multiparametric apoptosis detection using SYTO probes.
  • Demonstrated successful combination of SYTO probes with plasma membrane and mitochondrial potential markers.
  • Showcased the versatility of SYTO probes in diverse cell death assays.

Conclusions:

  • SYTO probes are effective for high-throughput, multiparametric analysis of apoptotic cell death.
  • These probes are valuable for tracking apoptosis in various cancer cell lines and primary samples.
  • The provided protocols enable advanced flow cytometry assays for cancer research.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...